S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q4 2023

Avoro Capital Advisors

Period: Q4 2023 Β· Filed: 2024-02-14
View on SEC EDGAR β†—
AUM
$7.24B
Total portfolio value
Positions
42
Reported securities
Top Holding
APLS
9.2% $665.1M
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
APLSAPELLIS PHARMACEUTICALS INC$665.1M9.19%$61.27β€”
9.2%
UTHRUNITED THERAPEUTICS CORP$628.6M8.68%$227.35$555.91+144.5%
8.7%
ASNDASCENDIS PHARMA$473.0M6.53%$127.53$274.50+115.2%
6.5%
ARGXARGENX SE$469.7M6.49%$381.00$939.68+146.6%
6.5%
MDGLMADRIGAL PHARMACEUTICALS INC$437.1M6.04%$226.86$528.10+132.8%
6.0%
SRPTSAREPTA THERAPEUTICS INC$418.9M5.79%$96.21$19.28-80.0%
5.8%
BMRNBIOMARIN PHARMACEUTICAL INC$414.6M5.73%$98.05$58.99-39.8%
5.7%
XBISPDR SERIES TRUST - S&P BIOTECH$396.8M5.48%$89.68$160.46+78.9%
5.5%
FOLDAMICUS THERAPEUTICS INC$388.8M5.37%β€”β€”
5.4%
CERECEREVEL THERAPEUTICS HLDNG$320.4M4.42%β€”β€”
4.4%
KRYSKRYSTAL BIOTECH INC$318.3M4.40%$124.96$375.07+200.2%
4.4%
MRTXMIRATI THERAPEUTICS INC$287.1M3.97%β€”β€”
4.0%
CBAYCYMABAY THERAPEUTICS INC$262.4M3.63%β€”β€”
3.6%
XENEXENON PHARMACEUTICALS INC$261.0M3.61%$44.91$60.96+35.7%
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$212.7M2.94%$194.93$312.78+60.5%
2.9%
ITCIINTRA-CELLULAR THERAPIES INC$161.5M2.23%β€”β€”
2.2%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$155.8M2.15%$59.55$18.95-68.2%
2.1%
KYMRKYMERA THERAPEUTICS INC$96.1M1.33%$25.35$113.51+347.8%
1.3%
GPCRSTRUCTURE THERAPEUTICS INC$95.1M1.31%$40.39$53.45+32.3%
1.3%
SNDXSYNDAX PHARMACEUTICALS INC$91.2M1.26%$21.86$21.82-0.2%
1.3%
BCRXBIOCRYST PHARMACEUTICALS INC$78.2M1.08%$6.07$9.84+62.1%
1.1%
IOVAIOVANCE BIOTHERAPEUTICS INC$54.5M0.75%$8.10$4.31-46.8%
0.8%
ROIVROIVANT SCIENCES LTD$52.2M0.72%$11.35$35.13+209.5%
0.7%
KURAKURA ONCOLOGY INC$42.9M0.59%$15.36$11.10-27.7%
0.6%
SYRESPYRE THERAPEUTICS INC$39.6M0.55%$21.40$86.63+304.8%
0.6%
KRTXKARUNA THERAPEUTICS INC$39.6M0.55%β€”β€”
0.6%
RCKTROCKET PHARMACEUTICALS INC$37.8M0.52%$29.50$3.84-87.0%
0.5%
ARWRARROWHEAD PHARMACEUTICALS INC$34.6M0.48%$31.01$83.99+170.8%
0.5%
MRNSMARINUS PHARMACEUTICALS INC$34.2M0.47%β€”β€”
0.5%
MNKDMANNKIND CORP$32.8M0.45%$3.92$4.52+15.3%
0.5%

Quarter-on-Quarter Activity

Q4 2023 vs. Q3 2023

New Positions (6)

TickerIssuerNotionalSince Filing
XBISPDR SERIES TRUST - S&P BIOTECH$396.8M+78.9%
ITCIINTRA-CELLULAR THERAPIES INC$161.5M
KRTXKARUNA THERAPEUTICS INC$39.6M
SLNOSOLENO THERAPEUTICS INC$31.6M
IMGNIMMUNOGEN INC$25.9M
TRMLTOURMALINE BIO INC$22.7M

Exited Positions (8)

TickerIssuerNotional
HZNPHORIZON THERAPEUTICS PLC$809.8M
SGENSEAGEN INC$373.3M
AKROAKERO THERAPEUTICS ORD$28.1M
TNGXTANGO THERAPEUTICS INC$25.0M
PMVPPMV PHARMACEUTICALS INC$18.4M
IKNAIKENA ONCOLOGY INC$7.1M
MCRBSERES THERAPEUTICS INC$6.0M
IOBTQIO BIOTECH INC$2.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SYRESPYRE THERAPEUTICS INC$39.4M+15951.1%+304.8%
CERECEREVEL THERAPEUTICS HLDNG$299.5M+690.7%
GPCRSTRUCTURE THERAPEUTICS INC$44.7M+133.3%+32.3%
MRUSMERUS N V$14.0M+100.0%
ARWRARROWHEAD PHARMACEUTICALS INC$19.4M+100.0%+170.8%
SNDXSYNDAX PHARMACEUTICALS INC$54.1M+65.2%-0.2%
VRCAVERRICA PHARMACEUTICALS INC$17.8M+35.4%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$41.8M+29.0%-68.2%

Trimmed (4)

TickerIssuerNotionalShares Ξ”Since Filing
NUVLNUVALENT INC$-24.2M-78.0%
RAREULTRAGENYX PHARMACEUTICAL INC$-36.7M-76.7%
MRTXMIRATI THERAPEUTICS INC$-3.3M-26.7%
KYMRKYMERA THERAPEUTICS INC$42.5M-2.1%+347.8%
← Back to Hedge Funds